Qualyst

Durham, United States Founded: 2012 • Age: 14 yrs Acquired By BioIVT
Biotech models for drug safety and interaction predictions are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Qualyst

Qualyst is a company based in Durham (United States) founded in 2012 was acquired by BioIVT in September 2017. Qualyst operates in a competitive market with competitors including Altis Biosystems, Toxys, ATANIS Biotech, Inovotion and Cytomyx Holdings, among others.

  • Headquarter Durham, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    BioIVT

    (Sep 07, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Qualyst

Headcount 50-200
Employee Profiles 127
Employee Profiles
People
Nadine Zainudeen
Business Development Manager
People
Dave Yoder
Senior Business Analyst
People
Kieran K.
European Operations Manager (Donor Centres)
People
Amelia Sugianto
Director Of Strategic Initiatives

Unlock access to complete

Funding Insights of Qualyst

Premium access

Detailed funding history for Qualyst

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Qualyst

Qualyst has secured backing from 1 investor. Prominent investors backing the company include BioIVT.

All
Investor Description Founded Year Domain Location
Provider of in vitro diagnostic products and assay services
Locked Locked Locked
Premium access

Investor details for Qualyst

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Qualyst

Investments
Premium access

Investment portfolio details for Qualyst

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Qualyst

Premium access

Detailed financials for Qualyst

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Qualyst Comparisons

Qualyst Primary company
Description
Biotech models for drug safety and interaction predictions a...
Location
Durham, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Qualyst

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Qualyst

Qualyst operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altis Biosystems, Toxys, ATANIS Biotech, Inovotion and Cytomyx Holdings, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of invitro platform for drug testing
Locked Locked Locked
In vitro genotoxicity testing services are provided using proprietary technology.
Locked Locked Locked
Developer of a cell-based assay for the diagnosis of allergies
Locked Locked Locked
Provider of in vivo oncology efficacy and toxicity assays for drug discovery and development
Locked Locked Locked
Cell-based assays for ion channel drug discovery are developed.
Locked Locked Locked
Molecular biology assays and kits are developed for microbiology labs.
Premium access

Detailed competitors of Qualyst

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Qualyst

Premium access

Complete news archive for Qualyst

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Qualyst

Qualyst was founded in 2012.

Qualyst is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Qualyst was founded in 2012 in Durham, United States, as a biotech firm focused on cell-based research tools. Drug transponders for in vitro in vivo correlation are supplied, with the hepatic in-vitro model relying on B-CLEAR technology to forecast hepatotoxicity, hepatic clearance, and human drug interactions. Services and products target efficacy, safety, and regulatory needs in pharmaceuticals, nutritional items, consumer goods, and industrial chemicals.

Qualyst's top competitors include Altis Biosystems, ABL Diagnostics and ATANIS Biotech.

Qualyst has 1 investor. Key investors include BioIVT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available